Nuron Biotech Inc.

Quick facts

Phase 3 pipeline

• NU100 · Multiple Sclerosis
  NU100 is a small molecule that targets the S1P1 receptor.
• rhIFN beta-1b · Immunology
  rhIFN beta-1b is a recombinant form of interferon beta-1b that modulates the immune system to reduce inflammation in the central nervous system.

Phase 2 pipeline

• NU300

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nuron Biotech Inc. portfolio CI brief
• Nuron Biotech Inc. pipeline updates RSS